We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note
Read MoreHide Full Article
In the latest trading session, Tilray Brands, Inc. (TLRY - Free Report) closed at $1.26, marking a +1.61% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.29%. At the same time, the Dow lost 0.37%, and the tech-heavy Nasdaq lost 0.34%.
Heading into today, shares of the company had lost 14.48% over the past month, lagging the Medical sector's loss of 0.33% and the S&P 500's gain of 3.08%.
Market participants will be closely following the financial results of Tilray Brands, Inc. in its upcoming release. It is anticipated that the company will report an EPS of -$0.03, marking a 25% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $206.83 million, up 3.39% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of -$0.11 per share and a revenue of $877.28 million, demonstrating changes of -1200% and +6.81%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for Tilray Brands, Inc. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.59% lower within the past month. Tilray Brands, Inc. currently has a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 106, positioning it in the top 43% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Tilray Brands, Inc. (TLRY - Free Report) closed at $1.26, marking a +1.61% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.29%. At the same time, the Dow lost 0.37%, and the tech-heavy Nasdaq lost 0.34%.
Heading into today, shares of the company had lost 14.48% over the past month, lagging the Medical sector's loss of 0.33% and the S&P 500's gain of 3.08%.
Market participants will be closely following the financial results of Tilray Brands, Inc. in its upcoming release. It is anticipated that the company will report an EPS of -$0.03, marking a 25% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $206.83 million, up 3.39% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of -$0.11 per share and a revenue of $877.28 million, demonstrating changes of -1200% and +6.81%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for Tilray Brands, Inc. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.59% lower within the past month. Tilray Brands, Inc. currently has a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 106, positioning it in the top 43% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.